BIOCRYST PHARMACEUTICALS, INC. Increase (Decrease) in Deferred Revenue
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Increase (Decrease) in Deferred Revenue of -$7.10 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-11-08
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-09-30 was -$100.00K.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$498.00K.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$327.00K.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was -$448.00K.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2017 was -$1.72M.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2016 was -$1.63M, a 236.03% decline from fiscal 2015.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2015 was $1.20M, a 72.93% decline from fiscal 2014.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2014 was $4.43M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$7.10M 10-Q · filed 2018-11-08 | ||
| 2018-06-30 | -$7.00M 10-Q · filed 2018-08-09 | |||
| 2017-12-31 | -$498.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$825.00K derived: sum of 2 quarters · filed 2018-11-08 | -$1.27M derived: sum of 3 quarters · filed 2018-11-08 | -$1.72M 10-K · filed 2018-03-12 |
| 2017-09-30 | -$327.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$775.00K derived: sum of 2 quarters · filed 2018-11-08 | -$1.22M 10-Q · filed 2018-11-08 | -$1.78M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | -$448.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$897.00K 10-Q · filed 2018-08-09 | -$1.45M derived: sum of 3 quarters · filed 2018-08-09 | -$1.60M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | -$449.00K 10-Q · filed 2018-05-09 | -$1.00M derived: sum of 2 quarters · filed 2018-05-09 | -$1.15M derived: sum of 3 quarters · filed 2018-05-09 | -$1.60M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | -$556.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$704.00K derived: sum of 2 quarters · filed 2018-03-12 | -$1.15M derived: sum of 3 quarters · filed 2018-03-12 | -$1.63M 10-K · filed 2018-03-12 |
| 2016-09-30 | -$148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$595.00K derived: sum of 2 quarters · filed 2017-11-08 | -$1.07M 10-Q · filed 2017-11-08 | -$1.48M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | -$447.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$927.00K 10-Q · filed 2017-08-08 | -$1.33M derived: sum of 3 quarters · filed 2018-03-12 | -$5.55M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | -$480.00K 10-Q · filed 2017-05-08 | -$883.00K derived: sum of 2 quarters · filed 2018-03-12 | -$5.10M derived: sum of 3 quarters · filed 2018-03-12 | $1.08M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | -$403.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$4.62M derived: sum of 2 quarters · filed 2018-03-12 | $1.56M derived: sum of 3 quarters · filed 2018-03-12 | $1.20M 10-K · filed 2018-03-12 |
| 2015-09-30 | -$4.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $1.96M derived: sum of 2 quarters · filed 2016-11-08 | $1.60M 10-Q · filed 2016-11-08 | $6.91M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $6.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $5.82M 10-Q · filed 2016-08-08 | $11.13M derived: sum of 3 quarters · filed 2017-02-27 | $10.83M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | -$359.00K 10-Q · filed 2016-05-09 | $4.95M derived: sum of 2 quarters · filed 2017-02-27 | $4.65M derived: sum of 3 quarters · filed 2017-02-27 | $4.37M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $5.31M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $5.01M derived: sum of 2 quarters · filed 2017-02-27 | $4.72M derived: sum of 3 quarters · filed 2017-02-27 | $4.43M 10-K · filed 2017-02-27 |
| 2014-09-30 | -$297.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$584.00K derived: sum of 2 quarters · filed 2015-11-06 | -$880.00K 10-Q · filed 2015-11-06 | -$1.24M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | -$287.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$583.00K 10-Q · filed 2015-08-07 | -$945.00K derived: sum of 3 quarters · filed 2016-02-26 | -$1.24M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | -$296.00K 10-Q · filed 2015-05-08 | -$658.00K derived: sum of 2 quarters · filed 2016-02-26 | -$952.00K derived: sum of 3 quarters · filed 2016-02-26 | -$1.25M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | -$362.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$656.00K derived: sum of 2 quarters · filed 2016-02-26 | -$951.00K derived: sum of 3 quarters · filed 2016-02-26 | -$1.10M 10-K · filed 2016-02-26 |
| 2013-09-30 | -$294.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$589.00K derived: sum of 2 quarters · filed 2014-11-07 | -$741.00K 10-Q · filed 2014-11-07 | -$952.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | -$295.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$447.00K 10-Q · filed 2014-08-08 | -$658.00K derived: sum of 3 quarters · filed 2015-03-02 | -$3.72M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | -$152.00K 10-Q · filed 2014-05-09 | -$363.00K derived: sum of 2 quarters · filed 2015-03-02 | -$3.42M derived: sum of 3 quarters · filed 2015-03-02 | -$2.05M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | -$211.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$3.27M derived: sum of 2 quarters · filed 2015-03-02 | -$1.90M derived: sum of 3 quarters · filed 2015-03-02 | -$9.58M 10-K · filed 2015-03-02 |
| 2012-09-30 | -$3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$1.69M derived: sum of 2 quarters · filed 2013-11-08 | -$9.37M 10-Q · filed 2013-11-08 | -$9.92M derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$6.30M 10-Q · filed 2013-08-08 | -$6.86M derived: sum of 3 quarters · filed 2014-03-10 | -$7.43M derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-03-31 | -$7.68M 10-Q · filed 2013-05-09 | -$8.23M derived: sum of 2 quarters · filed 2014-03-10 | -$8.81M derived: sum of 3 quarters · filed 2014-03-10 | -$8.61M derived: sum of 4 quarters · filed 2014-03-10 |
| 2011-12-31 | -$553.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | -$1.13M derived: sum of 2 quarters · filed 2014-03-10 | -$928.00K derived: sum of 3 quarters · filed 2014-03-10 | -$1.55M 10-K · filed 2014-03-10 |
| 2011-09-30 | -$574.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$375.00K derived: sum of 2 quarters · filed 2012-11-08 | -$999.00K 10-Q · filed 2012-11-08 | -$1.62M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-06-30 | $199.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$425.00K 10-Q · filed 2012-08-08 | -$1.05M derived: sum of 3 quarters · filed 2013-03-11 | -$1.67M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-03-31 | -$624.00K 10-Q · filed 2012-05-08 | -$1.25M derived: sum of 2 quarters · filed 2013-03-11 | -$1.87M derived: sum of 3 quarters · filed 2013-03-11 | |
| 2010-12-31 | -$624.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | -$1.25M derived: sum of 2 quarters · filed 2013-03-11 | -$2.50M 10-K · filed 2013-03-11 | |
| 2010-09-30 | -$625.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$1.87M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$1.25M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | -$2.56M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |